These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 4048244)

  • 1. Effects of naloxone on heroin-, amphetamine- and caffeine-stimulated locomotor activity in the rat.
    Swerdlow NR; Vaccarino FJ; Koob GF
    Pharmacol Biochem Behav; 1985 Sep; 23(3):499-501. PubMed ID: 4048244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Separate neural substrates of the locomotor-activating properties of amphetamine, heroin, caffeine and corticotropin releasing factor (CRF) in the rat.
    Swerdlow NR; Koob GF
    Pharmacol Biochem Behav; 1985 Aug; 23(2):303-7. PubMed ID: 3877311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nucleus accumbens opiate-dopamine interactions and locomotor activation in the rat: evidence for a pre-synaptic locus.
    Swerdlow NR; Amalric M; Koob GF
    Pharmacol Biochem Behav; 1987 Apr; 26(4):765-9. PubMed ID: 3110795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade of amphetamine but not opiate-induced locomotion following antagonism of dopamine function in the rat.
    Vaccarino FJ; Amalric M; Swerdlow NR; Koob GF
    Pharmacol Biochem Behav; 1986 Jan; 24(1):61-5. PubMed ID: 3080760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of naloxone and diprenorphine on amphetamine-stimulated behavior in guinea pigs and rats.
    Andrews JS; Holtzman SG
    Neuropharmacology; 1987 Aug; 26(8):1115-20. PubMed ID: 3658118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. D1 and D2 dopamine receptor antagonists block caffeine-induced stimulation of locomotor activity in rats.
    Garrett BE; Holtzman SG
    Pharmacol Biochem Behav; 1994 Jan; 47(1):89-94. PubMed ID: 7906891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of alpha-flupenthixol and naloxone on CRF-induced locomotor activation.
    Koob GF; Swerdlow N; Seeligson M; Eaves M; Sutton R; Rivier J; Vale W
    Neuroendocrinology; 1984 Nov; 39(5):459-64. PubMed ID: 6096752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dextro-naloxone counteracts amphetamine-induced hyperactivity.
    Chatterjie N; Sechzer JA; Lieberman KW; Alexander GJ
    Pharmacol Biochem Behav; 1998 Feb; 59(2):271-4. PubMed ID: 9476969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low doses of methylnaloxonium in the nucleus accumbens antagonize hyperactivity induced by heroin in the rat.
    Amalric M; Koob GF
    Pharmacol Biochem Behav; 1985 Sep; 23(3):411-5. PubMed ID: 4048236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A functional separation of behavioral stereotypy based on naloxone-reversible effects of seryl enkephalinamide: comparison with morphine.
    Broderick PA; Blaha CD; Lane RF
    Behav Brain Res; 1987 Apr; 24(1):31-8. PubMed ID: 3580113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Naloxone blockade of amphetamine place preference conditioning.
    Trujillo KA; Belluzzi JD; Stein L
    Psychopharmacology (Berl); 1991; 104(2):265-74. PubMed ID: 1876671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nucleus accumbens NMDA antagonist decreases locomotor activity produced by cocaine, heroin or accumbens dopamine, but not caffeine.
    Pulvirenti L; Swerdlow NR; Koob GF
    Pharmacol Biochem Behav; 1991 Dec; 40(4):841-5. PubMed ID: 1687766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions between enkephalin and dopamine in the control of locomotor activity in the rat: a new hypothesis.
    Agmo A; de Avila N
    Pharmacol Biochem Behav; 1985 Apr; 22(4):599-603. PubMed ID: 3991768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of naloxone upon motor activity induced by psychomotor stimulant drugs.
    Jones DN; Holtzman SG
    Psychopharmacology (Berl); 1994 Mar; 114(2):215-24. PubMed ID: 7838910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Centrally administered neurotensin suppresses locomotor hyperactivity induced by d-amphetamine but not by scopolamine or caffeine.
    Skoog KM; Cain ST; Nemeroff CB
    Neuropharmacology; 1986 Jul; 25(7):777-82. PubMed ID: 3748325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Naloxone reduces the neurochemical and behavioral effects of amphetamine but not those of cocaine.
    Schad CA; Justice JB; Holtzman SG
    Eur J Pharmacol; 1995 Feb; 275(1):9-16. PubMed ID: 7774666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of naloxone infusion upon spontaneous and amphetamine-induced activity.
    Jones DN; Holtzman SG
    Eur J Pharmacol; 1992 Oct; 221(1):161-5. PubMed ID: 1333971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of (+)- and (-)-Naloxone on the Acute Psychomotor-Stimulating Effects of Heroin, 6-Acetylmorphine, and Morphine in Mice.
    Eriksen GS; Andersen JM; Boix F; Bergh MS; Vindenes V; Rice KC; Huestis MA; Mørland J
    J Pharmacol Exp Ther; 2016 Aug; 358(2):209-15. PubMed ID: 27278234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Another look at amphetamine-induced stereotyped locomotor activity in rats using a new statistic to measure locomotor stereotypy.
    Mueller K; Hollingsworth EM; Cross DR
    Psychopharmacology (Berl); 1989; 97(1):74-9. PubMed ID: 2496430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lesions of the tegmental pedunculopontine nucleus: effects on the locomotor activity induced by morphine and amphetamine.
    Bechara A; van der Kooy D
    Pharmacol Biochem Behav; 1992 May; 42(1):9-18. PubMed ID: 1528951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.